Please enable JavaScript to continue using this application.

Compare $GLSI vs $IMRX | Chartloom

Compare

$GLSI vs $IMRX

Greenwich Lifesciences Inc · Immuneering Corp

GLSI

Greenwich Lifesciences Inc

IMRX

Immuneering Corp

Compare $GLSI vs $IMRX

Comparing Greenwich Lifesciences Inc and Immuneering Corp

GLSIGreenwich Lifesciences Inc

IMRXImmuneering Corp

GLSIGreenwich Lifesciences Inc

Market cap

$243M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-15.1%

52W performance

44.4%

FCF yield

-5.1%

IMRXImmuneering Corp

Market cap

$255M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-40.5%

52W performance

-39.4%

FCF yield

-22.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GLSI

IMRX

Detailed metrics comparison

GLSI

Greenwich Lifesciences Inc

IMRX

Immuneering Corp

Market Cap

GLSI$243M

IMRX$255M

Enterprise Value

GLSI$234M

IMRX$214M

Price

GLSI$16.53

IMRX$3.94

P/E Ratio

GLSIN/A

IMRXN/A

P/S Ratio

GLSI0.00x

IMRX526.64x

EV/Sales

GLSI0.00x

IMRX443.99x

EV/EBITDA

GLSI0.00x

IMRX0.00x

P/B Ratio

GLSI79.96x

IMRX1.38x

P/FCF Ratio

GLSIN/A

IMRXN/A

EV/FCF

GLSI-18.72x

IMRX-3.75x

PEG Ratio

GLSIN/A

IMRXN/A

Forward P/E (NTM)

GLSIN/A

IMRXN/A

Forward P/S (NTM)

GLSIN/A

IMRXN/A

Revenue (TTM)

GLSI$0

IMRX$0

Revenue Growth (YoY)

GLSIN/A

IMRXN/A

Forward Rev Growth

GLSI0.0%

IMRX100.5%

Gross Margin (TTM)

GLSI0.0%

IMRX28.0%

Operating Margin (TTM)

GLSI0.0%

IMRX0.0%

EBITDA Margin (TTM)

GLSI0.0%

IMRX0.0%

Net Margin (TTM)

GLSI0.0%

IMRX0.0%

FCF Margin (TTM)

GLSIN/A

IMRXN/A

Net Income (TTM)

GLSI$-22M

IMRX$-57M

FCF (TTM)

GLSI$-12M

IMRX$-57M

EPS (TTM)

GLSI-$1.48

IMRX-$0.89

ROE (TTM)

GLSI-79376.0%

IMRX-2715.0%

ROA (TTM)

GLSI-29531.0%

IMRX-2574.0%

ROIC (TTM)

GLSI-79376.0%

IMRX-2715.0%

Cash

GLSI$9M

IMRX$41M

Debt

GLSI$0

IMRX$0

Net Cash/Debt

GLSI$9M

IMRX$41M

Current Ratio (TTM)

GLSI1.54x

IMRX19.47x

Quick Ratio (TTM)

GLSI1.54x

IMRX18.47x

Debt/Equity (TTM)

GLSI0.00x

IMRX0.00x

Debt/Assets (TTM)

GLSI0.0%

IMRX0.0%

Interest Coverage (TTM)

GLSIN/A

IMRXN/A

Net Debt/EBITDA (TTM)

GLSI0.00x

IMRX0.00x

Beta

GLSI1.54

IMRX0.34

52W Performance

GLSI44.4%

IMRX-39.4%

YTD Performance

GLSI-15.1%

IMRX-40.5%

% from 52W High

GLSI-51.5%

IMRX-53.5%

% from 52W Low

GLSI112.5%

IMRX9.4%

Asset Turnover (TTM)

GLSI0.00x

IMRX0.00x

FCF Yield (TTM)

GLSI-5.1%

IMRX-22.4%

Earnings Yield (TTM)

GLSI-8.9%

IMRX-22.5%

Dividend Yield (TTM)

GLSIN/A

IMRXN/A

Rule of 40

GLSI0.0

IMRX0.0

EV/GP/RG

GLSIN/A

IMRXN/A

Ticker research

View GLSI research View IMRX research

Metric	GLSI Greenwich Lifesciences Inc	IMRX Immuneering Corp
Market & Valuation
Market Cap	$243M	$255M
Enterprise Value	$234M	$214M
Price	$16.53	$3.94
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	526.64x
EV/Sales	0.00x	443.99x
EV/EBITDA	0.00x	0.00x
P/B Ratio	79.96x	1.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.72x	-3.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	100.5%
Profitability
Gross Margin (TTM)	0.0%	28.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-22M	$-57M
FCF (TTM)	$-12M	$-57M
EPS (TTM)	-$1.48	-$0.89
ROE (TTM)	-79376.0%	-2715.0%
ROA (TTM)	-29531.0%	-2574.0%
ROIC (TTM)	-79376.0%	-2715.0%
Financial Health
Cash	$9M	$41M
Debt	$0	$0
Net Cash/Debt	$9M	$41M
Current Ratio (TTM)	1.54x	19.47x
Quick Ratio (TTM)	1.54x	18.47x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	0.34
52W Performance	44.4%	-39.4%
YTD Performance	-15.1%	-40.5%
% from 52W High	-51.5%	-53.5%
% from 52W Low	112.5%	9.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.1%	-22.4%
Earnings Yield (TTM)	-8.9%	-22.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View GLSI research	View IMRX research

Valuation

P/S Ratio

GLSI

0.00x

IMRX

526.64x

EV/FCF

GLSI

-18.72x

IMRX

-3.75x

Growth & revenue

Forward Revenue Growth

IMRX

100.5%

GLSI

0.0%

Profitability & performance

Gross Margin

IMRX

28.0%

GLSI

0.0%

ROE

IMRX

-2715.0%

GLSI

-79376.0%

FCF Yield %

GLSI

-5.1%

IMRX

-22.4%

52-Week Performance

GLSI

44.4%

IMRX

-39.4%

Detailed metrics comparison

GLSI

Greenwich Lifesciences Inc

IMRX

Immuneering Corp

Market Cap

GLSI$243M

IMRX$255M

Enterprise Value

GLSI$234M

IMRX$214M

Price

GLSI$16.53

IMRX$3.94

P/E Ratio

GLSIN/A

IMRXN/A

P/S Ratio

GLSI0.00x

IMRX526.64x

EV/Sales

GLSI0.00x

IMRX443.99x

EV/EBITDA

GLSI0.00x

IMRX0.00x

P/B Ratio

GLSI79.96x

IMRX1.38x

P/FCF Ratio

GLSIN/A

IMRXN/A

EV/FCF

GLSI-18.72x

IMRX-3.75x

PEG Ratio

GLSIN/A

IMRXN/A

Forward P/E (NTM)

GLSIN/A

IMRXN/A

Forward P/S (NTM)

GLSIN/A

IMRXN/A

Revenue (TTM)

GLSI$0

IMRX$0

Revenue Growth (YoY)

GLSIN/A

IMRXN/A

Forward Rev Growth

GLSI0.0%

IMRX100.5%

Gross Margin (TTM)

GLSI0.0%

IMRX28.0%

Operating Margin (TTM)

GLSI0.0%

IMRX0.0%

EBITDA Margin (TTM)

GLSI0.0%

IMRX0.0%

Net Margin (TTM)

GLSI0.0%

IMRX0.0%

FCF Margin (TTM)

GLSIN/A

IMRXN/A

Net Income (TTM)

GLSI$-22M

IMRX$-57M

FCF (TTM)

GLSI$-12M

IMRX$-57M

EPS (TTM)

GLSI-$1.48

IMRX-$0.89

ROE (TTM)

GLSI-79376.0%

IMRX-2715.0%

ROA (TTM)

GLSI-29531.0%

IMRX-2574.0%

ROIC (TTM)

GLSI-79376.0%

IMRX-2715.0%

Cash

GLSI$9M

IMRX$41M

Debt

GLSI$0

IMRX$0

Net Cash/Debt

GLSI$9M

IMRX$41M

Current Ratio (TTM)

GLSI1.54x

IMRX19.47x

Quick Ratio (TTM)

GLSI1.54x

IMRX18.47x

Debt/Equity (TTM)

GLSI0.00x

IMRX0.00x

Debt/Assets (TTM)

GLSI0.0%

IMRX0.0%

Interest Coverage (TTM)

GLSIN/A

IMRXN/A

Net Debt/EBITDA (TTM)

GLSI0.00x

IMRX0.00x

Beta

GLSI1.54

IMRX0.34

52W Performance

GLSI44.4%

IMRX-39.4%

YTD Performance

GLSI-15.1%

IMRX-40.5%

% from 52W High

GLSI-51.5%

IMRX-53.5%

% from 52W Low

GLSI112.5%

IMRX9.4%

Asset Turnover (TTM)

GLSI0.00x

IMRX0.00x

FCF Yield (TTM)

GLSI-5.1%

IMRX-22.4%

Earnings Yield (TTM)

GLSI-8.9%

IMRX-22.5%

Dividend Yield (TTM)

GLSIN/A

IMRXN/A

Rule of 40

GLSI0.0

IMRX0.0

EV/GP/RG

GLSIN/A

IMRXN/A

Ticker research

View GLSI research View IMRX research

Metric	GLSI Greenwich Lifesciences Inc	IMRX Immuneering Corp
Market & Valuation
Market Cap	$243M	$255M
Enterprise Value	$234M	$214M
Price	$16.53	$3.94
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	526.64x
EV/Sales	0.00x	443.99x
EV/EBITDA	0.00x	0.00x
P/B Ratio	79.96x	1.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-18.72x	-3.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	100.5%
Profitability
Gross Margin (TTM)	0.0%	28.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-22M	$-57M
FCF (TTM)	$-12M	$-57M
EPS (TTM)	-$1.48	-$0.89
ROE (TTM)	-79376.0%	-2715.0%
ROA (TTM)	-29531.0%	-2574.0%
ROIC (TTM)	-79376.0%	-2715.0%
Financial Health
Cash	$9M	$41M
Debt	$0	$0
Net Cash/Debt	$9M	$41M
Current Ratio (TTM)	1.54x	19.47x
Quick Ratio (TTM)	1.54x	18.47x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	0.34
52W Performance	44.4%	-39.4%
YTD Performance	-15.1%	-40.5%
% from 52W High	-51.5%	-53.5%
% from 52W Low	112.5%	9.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.1%	-22.4%
Earnings Yield (TTM)	-8.9%	-22.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View GLSI research	View IMRX research